INFLAMMACHECK
LIVE

Serial Number

79191246

Owner

Exhalation Technology Ltd

Attorney

Matthew A. Homyk

Filing Date

Feb 25, 2016

Add to watchlist:

No watchlists yet
View on USPTO

INFLAMMACHECK Trademark

Serial Number: 79191246 • Registration: 5253161

INFLAMMACHECK is a trademark filed by Exhalation Technology Ltd on February 25, 2016. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Exhalation Technology Ltd

Cambridge CB1 2JH , GB

Entity Type: 99

Trademark Details

Filing Date

February 25, 2016

Registration Date

August 1, 2017

Published for Opposition

March 14, 2017

Goods & Services

Medical apparatus and instruments in the nature of apparatus for the alleviation of breathing difficulties, namely, handheld diagnostic apparatus capable of analyzing exhalate and breath condensates with inbuilt software recommending what crisis treatment necessary to alleviate breathing difficulties being experienced by a patient; apparatus for use in collecting exhaled breath, namely, exhaled breath sample collection, analysis and reader instrumentation housed within a portable handheld unit and operating software sold therewith as a unit for use in the diagnosis of COPD crisis, COPD exacerbations, asthma events, pulmonary crisis events and the identification of condensates signaling the occurrence of a medical crisis; apparatus for use in analysing exhaled breath; apparatus for use in medical analysis, namely, computerized recording and analysis instrumentation for the diagnosis and treatment of respiratory conditions for medical use; medical apparatus for use in the investigation of metabolic disorders, namely, computerized recording and analysis instrumentation for the monitoring of metabolic functions; body rehabilitation apparatus for medical purposes; breath condensate and gas analysers for medical diagnostics; cases fitted for medical instruments; diagnostic apparatus for medical purposes, namely, instrumentation for monitoring heart rate, pulse oxymetary, breathing, gas analysis and respiratory events; [ medical instrumentation for monitoring heart rate, pulse oxymetary, breathing, gas analysis and respiratory events and software sold therewith as a portable handheld unit for medical use; medical diagnostic instruments sold in the form of kits comprised of breath and exhalate condensate specimen collection and identification kit and instructions, all for medical use by patients, their care givers and medical professionals in relation to breathing, gas analysis and respiratory events; ] medical testing apparatus and instruments for the detection of respiratory disorders sold as kits; medical apparatus for controlling pulmonary gas exchange parameters; medical apparatus for assisting breathing, namely, patient breathing system comprising artificial respiration apparatus for medical use; pulmonary diagnostic apparatus and instrumentation, namely, diagnostic instrumentation used for the detection of breathing anomalies, pulmonary function, pulmonary dysfunction and respiratory events for medical use; pulmonary function testing apparatus and instrumentation, namely, handheld breathing testing machines, handheld pulmonary function and pulmonary dysfunction testing machines for medical use; respiratory apparatus and instrumentation, namely, hand-held patient respiratory analysis equipment, and medical devices, namely, patient monitors and patient sensors for monitoring respiratory events; respiratory monitors for medical use; respiratory therapy apparatus and instrumentation, namely, medical instrumentation for diagnosing respiratory conditions, medical instrumentation for treating respiratory conditions; Probes for medical purposes, excluding probes used for blood glucose monitoring or diabetes care; probes for diagnostic purposes, excluding probes used for blood glucose monitoring or diabetes care; tools for medical diagnostics, namely, diagnostic instrumentation and software sold therewith as a handheld portable unit for medical use, excluding diagnostic instrumentation and software used for blood glucose monitoring or diabetes care; replacement parts and fittings for the aforesaid goods

Filing History

INTERNATIONAL REGISTRATION RENEWED
Feb 12, 2026 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Nov 28, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Nov 28, 2025 71AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jul 25, 2025 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Jan 29, 2025 PR71
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 30, 2024 EROP
POST REGISTRATION ACTION MAILED - SEC.71
May 15, 2024 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 8, 2024 APRE
TEAS SECTION 71 RECEIVED
Jul 31, 2023 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 1, 2022 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 20, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 24, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 3, 2017 FICS
FINAL DISPOSITION PROCESSED
Nov 3, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 1, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 1, 2017 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 27, 2017 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Jun 7, 2017 CHPB
ASSIGNED TO PETITION STAFF
Jun 7, 2017 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 2, 2017 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 16, 2017 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Mar 10, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 22, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 22, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 21, 2017 TROA
REFUSAL PROCESSED BY IB
Oct 13, 2016 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 19, 2016 RFCS
REFUSAL PROCESSED BY MPU
Sep 19, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 17, 2016 RFCR
NON-FINAL ACTION WRITTEN
Sep 16, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 13, 2016 MAFR
ASSIGNED TO EXAMINER
Sep 9, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 8, 2016 REPR